Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 8, 2019.
Article Versions
- You are currently viewing a previous version of this article (March 8, 2019 - 13:06).
- View the most recent version of this article
Copyright & Usage
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Sabine Maurer1,
- Peter Herhaus1,
- Romina Lippenmeyer2,
- Heribert Hänscheid2,
- Malte Kircher2,
- Andreas Schirbel2,
- H. Carlo Maurer3,
- Andreas K. Buck2,
- Hans-Jürgen Wester4,
- Hermann Einsele5,
- Götz-Ulrich Grigoleit5,
- Ulrich Keller6 and
- Constantin Lapa2
- 1 III. Medical Department, Hematology and Medical Oncology, Technische Universität München, Germany;
- 2 Department of Nuclear Medicine, University Hospital Würzburg, Germany;
- 3 II. Medical Department, Gastroenterology and Hepatology, Technische Universtät München, Germany;
- 4 Pharmaceutical Radiochemistry, Technische Universität München, Germany;
- 5 II. Medical Department, Hematology and Medical Oncology, University Hospital Würzburg, Germany;
- 6 Hematology, Oncology & Tumor Immunology (CBF), Charité - Universitätsmedizin
- For correspondence or reprints contact: Ulrich Keller, Hematology, Oncology & Tumor Immunology (CBF), Charité - Universitätsmedizin, Hindenburgdamm 30, Berlin 12203, Germany. E-mail: ulrich.keller@charite.de
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Theranostics in Hematooncology
- C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
- Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
- Biokinetics and Dosimetry of 177Lu-Pentixather
- CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma